Painting and Publishing Help Artist Survive Penile Cancer
Possibly no other form of cancer is more feared or less talked about than penile cancer. A series of paintings and a book published by London artist John D. Edwards is helping change that for the thousands of men diagnosed with the disease each year. In the early 1990s, Edwards discovered a lump in his [...]
click here to read full article...STAT3 Inhibitors Can Help or Harm Glioblastoma Patients
A study led by the Harvard School of Medicine provides evidence that targeted chemotherapies commonly used to treat glioblastoma may do more harm than good for some patients. Glioblastoma is a rare form of brain cancer with a poor survival rate. STAT3 inhibitors are one of the few therapies available to treat the disease, but [...]
click here to read full article...Minnesota Kids Get Laughing Gas Before Cancer Treatments
Children’s Hospitals and Clinics of Minnesota has won the Innovation of the Year in Patient Care Award from the Minnesota Hospital Association for making chemotherapy, CT scans and other medical procedures less frightening for children. Children’s Hospitals and Clinics have been using nitrous oxide, a mild sedative commonly referred to as laughing gas, to relax [...]
click here to read full article...John Wayne Ties CCR9 to Metastatic Melanoma in GI Tract
Research conducted by the John Wayne Cancer Institute (JWCI) at Saint John’s Health Center indicates the receptor protein CCR9 may promote the spread of melanoma to the small intestine. Unlike other cancers, melanoma skin cancer commonly metastasizes to the lower bowel and, until recently, scientists were at a loss to explain the connection. JWCI’s study [...]
click here to read full article...Europe OKs Oral Chemo for Advanced Colorectal Cancer
Patients being treated for metastatic colorectal cancer in Europe just got a new treatment option. Capecitabine, which is marketed by Switzerland-based pharmaceutical company Roche under the trade name Xeloda, has been approved by the European Commission for the treatment of metastatic colorectal cancer. European health officials approved the oral tablets for use in combination with [...]
click here to read full article...DoD Makes Mesothelioma Research Money Available
The US Department of Defense (DoD) Medical Research Program is making mesothelioma research a priority for the 2008 grant cycle, a move which potentially makes millions of grant dollars available to civilian scientists studying the deadly disease. Mesothelioma, a rare cancer strongly linked to asbestos exposure, occurs at elevated rates in certain populations of military [...]
click here to read full article...PI3K Signals Impact Breast and Ovarian Cancer Prognosis
Researchers from the University of Minnesota and Duke University have discovered how specific proteins regulate genes responsible for turning cancer cells on or off in women with breast and ovarian cancers. To arrive at their finding, the team studied 408 breast cancer patients and 153 ovarian cancer patients. Their investigation revealed that increased activity in [...]
click here to read full article...Argonne Analysis Shows Surprising Activity in Proteins
Research conducted at the US Department of Energy’s Argonne National Laboratory has produced some surprising information about the activities of proteins. Their discoveries could offer cancer researchers important new clues about how these crucial molecules interact with oncology drugs and other medicines. For over one hundred years, standard models of protein behavior have portrayed them [...]
click here to read full article...Cancer Patients Seek National Policy on Fertility Treatment
Approximately 11,000 people between the ages of 15 and 40 are diagnosed with cancer each year in England. While many patients in this age group go on to become long-term cancer survivors, a large percentage of them are rendered infertile as a result of their cancer treatments. Modern medicine continues to offer new options for [...]
click here to read full article...Light-Activated Compound Kills Cisplatin-Resistant Cancer
A team of international researchers has discovered a platinum-based compound which is activated by light and potent enough to kill cancers resistant to Cisplatin treatments. Scientists from the University of Warwick, the University of Edinburgh, the University of Dundee and the Czech Republic’s Institute of Biophysics found the new compound, known as light-activated PtIV complex, [...]
click here to read full article...
